10-Q: Dynatronics Faces Going Concern Doubt Amid Revenue Decline

Dynatronics Corporation reported a reduced net loss for Q1 FY2026, but faces substantial doubt about its ability to continue as a going concern due to declining revenues, negative operating cash flows, and a loan default.

Summary

• Dynatronics Corporation reported a net loss of $201,857 for the three months ended September 30, 2025, an improvement from a net loss of $366,648 in the prior year period.
• Net sales decreased by 7.6% to $7,024,027 for the quarter, down from $7,602,249 in the same period last year, primarily due to reduced OEM customer volume and lower demand for orthopedic soft bracing products.
• Gross profit declined by 12.6% to $1,731,629, with the gross profit margin decreasing from 26.1% to 24.7%.
• Selling, general, and administrative (SG&A) expenses decreased significantly by 18.5% to $1,820,092, driven by reductions in salaries, benefits, and other professional expenses.
• The company's operating loss improved to $(88,463) from $(250,996) in the prior year quarter.
• Cash and cash equivalents increased to $761,748 as of September 30, 2025, from $326,344 as of June 30, 2025, largely due to increased draws on its line of credit.
• Working capital decreased to $592,564 as of September 30, 2025, from $718,110 as of June 30, 2025.
• The company received a notice of default on September 16, 2025, from its lender, Gibraltar Business Capital, LLC, for failing to comply with its fixed charge coverage ratio covenant.
• Management has identified substantial doubt about the company's ability to continue as a going concern due to recurring operating losses, negative cash flows, and reduced liquidity.
• Preferred stock dividends of $183,550 were paid by issuing 2,557,952 shares of common stock in October 2025, contributing to a significant increase in weighted average shares outstanding.

Sentiment

Score: 2

Explanation: Despite a reduced net loss, the overall sentiment is highly negative due to significant concerns about the company's ability to continue as a going concern, a loan default, declining revenues, negative operating cash flow, and potential future tariff impacts. The strategic plans are forward-looking and not guaranteed.

Positives

• Net loss decreased by $164,791 to $201,857 for the quarter ended September 30, 2025, compared to $366,648 in the prior year.
• Operating loss significantly improved to $(88,463) from $(250,996) in the same period last year.
• Selling, general, and administrative expenses decreased by $411,711, or 18.5%, primarily due to reductions in salaries, benefits, and professional expenses.
• Cash and cash equivalents increased to $761,748 as of September 30, 2025, from $326,344 as of June 30, 2025.
• Net loss per common share improved to $(0.03) from $(0.09) in the prior year quarter.

Negatives

• Net sales decreased by $578,222, or 7.6%, to $7,024,027 for the quarter ended September 30, 2025.
• Gross profit decreased by $249,178, or 12.6%, and gross profit margin declined from 26.1% to 24.7%.
• The company incurred negative cash flows from operating activities of $(93,317) for the quarter, a reversal from positive cash flow of $100,646 in the prior year.
• Working capital decreased to $592,564 as of September 30, 2025, from $718,110 as of June 30, 2025.
• Accumulated deficit increased to $(40,897,408) as of September 30, 2025, from $(40,512,001) as of June 30, 2025.
• The company received a notice of default from its lender for failing to comply with a financial covenant.
• Substantial doubt exists about the company's ability to continue as a going concern.
• Significant dilution occurred due to the issuance of 2,557,952 common shares to pay preferred stock dividends.

Risks

• Substantial doubt about the company's ability to continue as a going concern within one year due to recurring operating losses, negative cash flows, and continued reduction in liquidity.
• Default on the Loan and Security Agreement with Gibraltar Business Capital, LLC for failure to comply with the fixed charge coverage ratio, allowing the lender to exercise remedies.
• Increased risks and uncertainties from recent U.S. and China tariff changes, potentially leading to a significant adverse impact on future costs of revenue.
• Uncertainties in the broader economic environment, global supply chain disruptions, higher personnel costs, and changes to customer or product mix could adversely affect liquidity and cash.
• No assurance that additional capital, if needed, will be available on satisfactory terms or at all.
• The company's ability to successfully implement strategic actions to mitigate going concern factors is not guaranteed.
• The formula for paying preferred stock dividends in common stock can change the effective yield to more or less than 8% depending on the market price, potentially leading to further dilution.

Future Outlook

The company anticipates a significant adverse impact on future costs of revenue if universal tariffs are implemented as initially announced in April 2025. Management is creating a comprehensive plan to address challenges, including cost reduction, streamlining operations, pursuing new revenue streams through product diversification, and transitioning production in-house. They are also evaluating inventory to reduce exposure and convert excess to cash. There is no guarantee these strategic actions will successfully mitigate the substantial doubt about the company's ability to continue as a going concern.

Management Comments

• Management believes that if it successfully implements strategic actions, it has a chance to mitigate the factors giving rise to substantial doubt about its going concern ability; however, there is no guarantee of success.
• The shift to in-house production aims to reduce costs by eliminating third-party markups, enhance quality control, and improve supply chain reliability.
• The company is proactively working with suppliers to mitigate potential tariff-related costs and has stocked adequate inventory of certain key products and components.

Industry Context

Dynatronics operates in the medical device sector, specifically targeting physical therapy, rehabilitation, orthopedics, pain management, and athletic training markets. The reported decline in net sales, particularly in orthopedic soft bracing products, suggests potential headwinds in these specific segments or increased competitive pressures. The broader economic environment and global supply chain uncertainties are noted as affecting the industry, impacting liquidity and cash flow for companies like Dynatronics.

Comparison to Industry Standards

• NA

Related Party Transactions

• The company leases office, manufacturing, and warehouse facilities in Northvale, New Jersey from employees, shareholders, and entities controlled by shareholders.
• Combined expenses for these related-party transactions totaled $189,580 for the three months ended September 30, 2025, a decrease from $337,225 in the prior year.
• As of April 2025, the Minnesota facility lease is no longer associated with related parties.

Stakeholder Impact

• Shareholders face significant risk due to the 'going concern' warning, loan default, and potential for further dilution from preferred stock dividends paid in common stock.
• Creditors, particularly Gibraltar Business Capital, LLC, have reserved rights to exercise remedies due to a loan default, indicating increased risk for lenders.
• Employees may be impacted by cost reduction initiatives and operational streamlining efforts.
• Customers might see changes in product availability or pricing due to inventory management strategies and potential tariff impacts.
• Suppliers may be affected by the company's efforts to mitigate tariff-related costs and adjust inventory purchases.

Next Steps

• Implement cost reduction initiatives.
• Streamline operational processes.
• Pursue new revenue streams through product diversification.
• Transition production of therapeutic modalities from contract manufacturer to internal operations.
• Evaluate current inventory position and promote discounted prices to convert excess inventory to cash.
• Add to sales efforts to improve revenue.
• Consider additional options to improve operating efficiency and enhance liquidity.

Key Dates

Recommendation

The filing presents a dire financial situation for Dynatronics Corporation. The explicit 'substantial doubt about the Company's ability to continue as a going concern' is a critical red flag for investors. This is compounded by a recent default on its primary line of credit, indicating a breach of financial covenants and potential acceleration of debt. While the net loss decreased, this was largely driven by significant cuts in SG&A, masking a continued decline in net sales and gross profit margin, and a shift to negative operating cash flow. The reliance on increased draws from a now-defaulted line of credit to boost cash reserves is unsustainable. The company's strategic plans are aspirational and offer no guarantee of success in mitigating these severe risks. Given the high level of uncertainty, the loan default, and fundamental operational challenges, a seasoned investor would likely recommend a strong sell to minimize exposure to potential significant capital loss.

Keywords

Medical Devices, Physical Therapy, Rehabilitation, Orthopedics, Pain Management, Athletic Training, SEC Filing, 10-Q, Financial Results, Going Concern, Loan Default, Tariffs, Liquidity, Net Sales, Gross Profit, Operating Loss, Cash Flow, Dynatronics